Bone morphogenetic proteins and the polycystic ovary syndrome

BMP system expression in GCs from polycystic ovary syndrome women and the in vitro effects of BMP4, BMP6, and BMP7 on GC steroidogenesis

(2012) Mohamad Khalaf et al.   EUROPEAN JOURNAL OF ENDOCRINOLOGY

Serum anti-Müllerian hormone and inhibin B concentrations are not useful predictors of ovarian response during ovulation induction treatment with recombinant follicle-stimulating hormone in women with polycystic ovary syndrome

(2011) Sharon Lie Fong et al.   FERTILITY AND STERILITY

Association of serum bone morphogenetic protein 4 levels with obesity and metabolic syndrome in non-diabetic individuals

(2010) Jang-Won Son et al.   ENDOCRINE JOURNAL

Androgen circle of polycystic ovary syndrome

(2009) R. Homburg   HUMAN REPRODUCTION

Growth factor release following femoral nailing

(2008) Peter V. Giannoudis et al.   BONE

Serum levels of MMP-3 and cathepsin K in patients with ankylosing spondylitis: Effect of TNFα antagonist therapy

(2008) Daniel Wendling et al.   JOINT BONE SPINE

A Functional Anti-Müllerian Hormone Gene Polymorphism Is Associated with Follicle Number and Androgen Levels in Polycystic Ovary Syndrome Patients

(2008) Marlies E. Kevenaar et al.   JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM

Increased Myocardial Collagen Turnover in Patients with Progressive Cardiac Conduction Disease

(2008) YASEMIN T. BOZKAYA et al.   PACE-PACING AND CLINICAL ELECTROPHYSIOLOGY

Relationship of bone morphogenetic proteins to disease activity and radiographic damage in patients with ankylosing spondylitis

(2008) M‐C. Park et al.   SCANDINAVIAN JOURNAL OF RHEUMATOLOGY